Wall Street PR

Shareholder Takeaway: Tower Group International, Ltd. (NASDAQ:TWGP), Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP), EDENOR S.A. (ADR) (NYSE:EDN)

Boston, MA 07/02/2014 (wallstreetpr) – Doubts over the deal between Tower Group International, Ltd. (NASDAQ:TWGP) and ACP Re appear to be reducing. The stock gained more than 8 percent in the previous session amid heavy volume of shares changing hands. The gain followed a series of descent that hinged on the fears over the deal being completed.

Tower Group (NASDAQ:TWGP) has agreed to be purchased by ACP Re at a time when it is faced with challenging financial situation. The deal values the company at $2.50 per share. However, the deal was initially valued at $3 per share.

 The company has had little to write home about except its expanding losses and debt position.

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced that the Phase 3 study of its irritable bowel condition  treatment, Xifaxan, showed impressive results that put the company on the right path to commercialization of the drug.

Shares of the company jumped more than 11 percent on the encouraging development.

Although the company provided few statistical details about the late-stage trial, it said the drug significantly improved the condition in 14 days compared with patients placed on a placebo.

The company did not provide details about FDA filing, but analysts believe that it could file for the commercialization of the drug in August to allow for the launch of the drug early next year.

Jason Gerberry, an analyst with Leerink, expects Salix (NASDAQ:SLXP) to fetch addition $700 million in annual sales by 2019 because of Xifaxan. At Sterne Agee, analysts expect the drug to add $128 million in sales next year and $695million by 2018.

The company earned $1.05 per share in the most recent quarter reporting, beating Wall Street consensus estimate at $0.91. Revenue for the quarter also breached expectations at $384 million against $373.91 million.

EDENOR S.A. (ADR) (NYSE:EDN) had an interesting day on New York Stock Exchange yesterday. The stock gained more than 7 percent on volume that exceeded the daily average. The stock also touched a new 52-week high on the widely exciting day as investors once again reaffirmed their confidence in the future of the electricity company.

Published by Steve Hackney

Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.